HIV

HIV

Interactive Data Dashboards

Track the HIV & TB response

Live indicators, province breakdowns and downloadable data.

  • Women living with HIV, still waiting on redress after ‘forced sterilisations’

    Almost nine months since the Commission on Gender Equality (CGE) released a damning report with dozens of women living with HIV’s testimonies about forced sterilisations allegedly performed on them in public health facilities, the Department of Health has now moved to implement the Commission’s recommendations. Nomfundo Xolo reports.

    ·

  • HIV and circumcision: Where are we at the end of 2020?

    Voluntary Medical Male Circumcision has been shown to reduce the risk of female-to-male HIV transmission by 60%. But with the COVID-19 pandemic and the associated lockdown, health authorities and organisations conducting VMMC in South Africa, say the numbers of men and boys being medically circumcised have dropped dramatically. Siyabonga Kamnqa reports.

    ·

  • HIV death rate in SA men much higher than in women

    While men account for only a third of South Africa’s roughly 200 000 new HIV infections in the year ending mid-2019, they account for more than half of the approximately 74 000 HIV-related deaths in the same period. This is according to new estimates released on Tuesday from the Thembisa mathematical model of HIV in South Africa.

    ·

  • HIV prevention injection hailed as a “major breakthrough” for women

    Early results from a pivotal trial of an HIV prevention injection announced by the University of the Witwatersrand researchers have been hailed as being a “game-changer” to turn “the tide on HIV” as it effectively reduces HIV acquisition and provides women more choices in how to protect themselves. Amy Green reports.

    ·

  • TB treatment time cut by a third

    A new four-month treatment course for drug-sensitive tuberculosis (the most common form of TB by far) is as safe and effective as the current six-month treatment course that has been in use since the 1980s, according to findings from a large new study. Amy Green reports.

    ·

  • Interview: Dr Thembisile Xulu – the new CEO of SANAC

    Dr Thembisile Xulu was recently appointed as the new CEO of the South African National AIDS Council (SANAC). On her second day in office, Bienne Huisman spoke to Xulu about her new role, her love of medicine, and growing up in a family of strong women.

    ·

  • 1.3m switched to new ARV, but weight gain is a concern

    Two years after it was announced that the ARV dolutegravir would become part of standard first line HIV treatment in South Africa, it is finally reaching significant numbers of people. But new research about a worrying side-effect, weight gain (particularly in women), has muddied its otherwise stellar reputation.

    ·

  • Vaginal ring ushers in new era in HIV prevention

    A recent announcement about a vaginal ring to prevent HIV has AIDS activists and women’s sexual and reproductive health advocates excited. But where would this ring fit in South Africa’s HIV prevention programme? Amy Green investigates.

    ·